Indian scientists have developed a path-breaking technique which will allow doctors to diagnose patients for various life-threatening chronic diseases in a few hours as opposed to 3-7 days which a normal diagnosis takes. XCyton Diagnostics, a Bangalore-based firm has found a way to immediately identify multiple organisms responsible for infections. Not only that, but reports suggest that the system is four times more precise than conventional tests. “Research is an uncertain game. The journey to reach to this invention has been phenomenal,” said XCyton founder BV Ravi Kumar, who has received a patent for the invention.
The system can identify multiple organisms, including bacteria, viruses, fungi and parasites in a specific test from a single sample. Diagnostic cultures are commonly used to identify infectious microbes, parasites from samples isolated from blood, spinal cord, urine, stool, genital tract, throat and skin. This can take 3-7 days.
“Correct therapy and outcomes start with correct diagnosis. XCyton will provide a novel way of rapidly diagnosing critical care infections” said Kiran Mazumdar-Shaw. The Biocon founder invested an undisclosed seed capital in XCyton a few years back, when it was struggling to sell its products in the market and was not able to get grants to pursue scientific research. “I said if I lose this money it doesn’t matter. I am happy I did not let Ravi Kumar give up,” she said. The other early stage investor includes Amvar Ventures, a sister concern of Nadathur Holdings, an investment firm established by NS Ragahavan, one of the co-founders of Infosys.